K Number
K013618
Manufacturer
Date Cleared
2002-08-14

(282 days)

Product Code
Regulation Number
872.4760
Panel
Dental
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Indicated for use as a mandibular bone lengthener for patients diagnosed with conditions where treatment includes mandibular distraction osteogenesis. These conditions may include diagnoses such as mandibular micrognathia or hemifacial microsomia. The OsteoMed Intraoral Mandibular Distraction System is intended for single patient use only.

Device Description

The OsteoMed Intraoral Mandibular Distraction System is a subcutaneous bone distractor. It features various curved and straight bars activated with a threaded wire that has screw holes that are fixed to bone via 1.6mm/2.0mm bone screws. The distractor is available in two sizes and in right and left versions. The threaded wire is activated by a hex driver and is capable of distraction lengths of up to 35mm.

AI/ML Overview

I'm sorry, but the provided text does not contain the information required to describe acceptance criteria or a study proving device performance. The document is a 510(k) summary and FDA clearance letter for the OsteoMed Intraoral Mandibular Distraction System. It details the device's intended use, description, and claims of substantial equivalence to predicate devices, but it does not include:

  • A table of acceptance criteria and reported device performance.
  • Details about a study with sample sizes, data provenance, ground truth establishment, or expert involvement.
  • Information on MRMC comparative effectiveness studies or standalone algorithm performance.

The document states that "Due to the similarity of materials and design to both pre-enactment and postenactment devices, OsteoMed believes that the OsteoMed Intraoral Mandibular Distraction System does not raise any new safety or effectiveness issues." This suggests that the clearance was based on equivalence rather than new performance studies demonstrating against specific acceptance criteria.

{0}------------------------------------------------

AUG 1 4 2002

Image /page/0/Picture/1 description: The image shows a sequence of handwritten alphanumeric characters. The characters are "KO13618". The characters are written in black ink on a white background.

Image /page/0/Picture/2 description: The image shows the logo for Osteomed Corporation. The text "OSTEOMED" is in large, bold, sans-serif font. Below that, in a smaller font, is the word "CORPORATION".

510(k) Summary

Device Proprietary Name:OsteoMed Intraoral MandibularDistraction System
Device Common Name:Intraoral Distractor
Classification Name:MQN, External MandibularFixator and/or Distractor
Name of Submitter:OsteoMed Corporation3750 Realty RoadAddison, Texas 75001Phone: (972) 241-3401Fax: (972) 241-3507
Contact Person:Dawn T. Holdeman
Date Prepared:October 31, 2001

Summary:

This submission describes the OsteoMed Intraoral Mandibular Distraction System indicated for use as a mandibular bone lengthener for patients diagnosed with conditions where treatment includes mandibular distraction osteogenesis. These conditions may include diagnoses such as mandibular micrognathia or hemifacial microsomia. The OsteoMed Intraoral Mandibular Distraction System is intended for single patient use only.

The OsteoMed Intraoral Mandibular Distraction System is a subcutaneous bone distractor. It features various curved and straight bars activated with a threaded wire that has screw holes that are fixed to bone via 1.6mm/2.0mm bone screws. The distractor is available in two sizes and in right and left versions. The threaded wire is activated by a hex driver and is capable of distraction lengths of up to 35mm.

Equivalence for this device is based on similarities in intended use, material, design and operational principle to the OsteoMed Intraoral Distraction System (K990944), Leibinger Vazquez-Diner Intraoral Distraction Device (K964649) and the Howmedica Guerrero-Bell Distractor (K972166).

Due to the similarity of materials and design to both pre-enactment and postenactment devices, OsteoMed believes that the OsteoMed Intraoral Mandibular Distraction System does not raise any new safety or effectiveness issues.

Image /page/0/Picture/11 description: The image shows the Marmon logo and the text "A member of The Marmon Group of companies". The logo is a stylized "M" with four vertical bars. The text is in a smaller font and is located to the right of the logo. The image is simple and clean, with a focus on the Marmon brand.

{1}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized human face in profile, with three overlapping silhouettes suggesting a sense of community or interconnectedness. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the face, emphasizing the organization's name and national affiliation.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 1 4 2002

Ms. Dawn T. Holdeman Regulatory Affairs & Document Control OsteoMed Corporation 3750 Realty Road Addison, Texas 75001-4311

Re: K013618

Trade/Device Name: Intraoral Mandibular Distraction System Regulation Number: Bone Plate Regulation Name: 872.4760 Regulatory Class: II Product Code: MQN Dated: June 4, 2002 Received: June 5, 2002

Dear Mr. Holdeman:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

{2}------------------------------------------------

Page 2 – Ms. Holdeman

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); v 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594- 4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely vours.

Patricia Caccavellor

Timothy A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

OsteoMed "Indications for Use" Submission

510(k) Number: 4013618 _______________________________________________________________________________________________________________________________________________________

Device Name:Osteomed Intraoral MandibularDistraction System
Indication for Use:Indicated for use as a mandibular bonelengthener for patients diagnosed withconditions where treatment includesmandibular distraction osteogenesis.These conditions may includediagnoses such as mandibularmicrognathia or hemifacial microsomia.The OsteoMed Intraoral MandibularDistraction System is intended forsingle patient use only.

Susan Roares

(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices

510(k) Number: K(1)3(1)8

§ 872.4760 Bone plate.

(a)
Identification. A bone plate is a metal device intended to stabilize fractured bone structures in the oral cavity. The bone segments are attached to the plate with screws to prevent movement of the segments.(b)
Classification. Class II.